NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc. is a United States-based company headquartered in Emeryville, California. With 64 employees, the company generates $9.2 million in annual revenue. NovaBay Pharmaceuticals develops and sells a range of eyecare and wound care products. Their flagship product, Avenova Antimicrobial Lid & Lash Solution, is a clinically proven treatment for blepharitis and dry-eye disease. This solution, formulated with a patented form of hypochlorous acid, is available to both consumers and eyecare professionals. The company also offers a suite of complementary eyecare products, including lubricating eye drops, warm eye compresses, an antioxidant-rich oral supplement, and eyelid health monitoring device. NovaBay's wound care products, marketed under the PhaseOne® and NeutroPhase® brands, are distributed in the U.S. and China. NovaBay's commitment to scientific innovation is evident in its formulation of products with clinically-proven efficacy. Their focus on addressing a variety of eye health concerns, from bacterial infections to dryness, allows them to cater to a diverse range of patients. For more information about NovaBay Pharmaceuticals and their products, visit www.novabay.com.